Specializing In:
- Rheumatology and immune-mediated inflammatory diseases
- Transplant and cell therapy for non-malignant conditions
- Immune-related complications of transplant, cell-therapy and cancer immunotherapies.
Research Interests:
- Transplant and Cell therapy for severe or refractory autoimmune diseases
- Treatment and prevention of Graft vs Host Disease (GvHD)
- Rheumatologic complications of cancer immunotherapy
Biography
I am a Med/Peds rheumatologist specializing in the clinical management of immune-mediated inflammatory diseases and treatment-related toxicities, including refractory autoimmune disease, graft-versus-host disease (GvHD), immunotherapy-related and other systemic autoinflammatory syndromes. My clinical and translational research focuses on the intersection of rheumatology, transplantation, and cell therapy, with an emphasis on improving outcomes for patients with complex immune dysregulation.
I am a member of the Transplant and Cell Therapy team at Roswell Park, working to improve transplant access, outcomes and expand innovative cellular therapies to patients with severe autoimmune diseases. I also provide specialized rheumatology care for transplant and oncology patients as part of a multidisciplinary effort to optimize patient outcomes.
Positions
Roswell Park Comprehensive Cancer Center
- Assistant Professor of Oncology
- Department of Medicine - Transplant & Cellular Therapy
Background
Education and Training
- 2007–2011 - MD - State University of New York at Buffalo School of Medicine & Biomedical Sciences, Buffalo, NY
- 2005-2007 - MS - State University of New York at Buffalo and Roswell Park Cancer Institute, Buffalo, NY
- 1999-2003 - BS - Cornell University College of Human Ecology, Ithaca, NY
Residency
- 2011–2015 - Internal Medicine & Pediatrics Residency, University of Rochester, Rochester, NY
Fellowship
- 2015–2019 - Adult & Pediatric Rheumatology Fellowship, University of Rochester, Rochester, NY
Board Certification
- American Board of Internal Medicine - Internal Medicine
- American Board of Internal Medicine - Adult Rheumatology
- American Board of Pediatric Medicine - Pediatric Medicine
- American Board of Pediatric Medicine - Pediatric Rheumatology
- American Board of Obesity Medicine - Obesity Medicine
Professional Memberships
- American College of Rheumatology (ACR)
- Childhood Arthritis and Rheumatology Research Alliance (CARRA)
- American Society of Gene and Cell Therapy (ASGCT)
Honors & Awards
- 2016 - Clausen Research Fellowship, University of Rochester Medical Center
- 2011 - UB Alpha Omega Alpha Medical Honor Society
- 2010 - Foundation of the Consortium of MS Centers Research Scholar Grant
- 2009 - AAAAI Research Fellowship Grant
- 2008 - AAAAI Chrysalis Project Award
- 1999–2003 - Cornell Presidential Research Scholar
Publications
Krishnan J, Karki S, Rawleigh A, Fitzgerald V, Kalinski P, Lieberman A and Gandhi S. Immune Checkpoint Inhibitor–Induced Sicca Syndrome: Early Recognition Is Key. AIM Clinical Cases. 2025;4:e241256.
Bell RD, Rahimi H, Kenney HM, Lieberman AA, Wood RW, Schwarz EM, Ritchlin CT. Altered Lymphatic Vessel Anatomy and Markedly Diminished Lymph Clearance in Affected Hands of Patients With Active Rheumatoid Arthritis. Arthritis & Rheumatology. 2020;72(9):1447–1455.
Dziwis J, Agnihothri R, Lieberman A, Richardson CT. A Unique Case of Dermatomyositis Associated with Anti-TIF1γ Antibody and Chondrosarcoma. JAAD Case Reports. 2019;5(9):828–830.
Lieberman A, et al. Differential Expression of Receptor Activator of NF-κB Ligand (RANKL) by Epidermal Keratinocytes in Psoriatic Arthritis Versus Psoriasis. Psoriasis Forum. 2014;20(4):179. Presented at GRAPPA Annual Meeting 2014.
Lieberman A, et al. Effect of Retinoic Acid on the Expression of the Receptors That Regulate B-Cell Homeostasis: TACI, BAFF-R, and BCMA. Journal of Allergy and Clinical Immunology. 2009;123(2 Suppl):S138. Oral presentation at the American Academy of Allergy, Asthma & Immunology Annual Meeting.